{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:01:16Z","timestamp":1788051676197,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000121","name":"Division of Mathematical Sciences","doi-asserted-by":"publisher","award":["DMS-2451660"],"award-info":[{"award-number":["DMS-2451660"]}],"id":[{"id":"10.13039\/100000121","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Biol Eng Comput"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s11517-026-03606-z","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:36:53Z","timestamp":1782790613000},"page":"2747-2768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating a relation between amyloid beta plaque burden and accumulated neurotoxicity caused by amyloid beta oligomers"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-6907","authenticated-orcid":false,"given":"Andrey V.","family":"Kuznetsov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"3606_CR1","doi-asserted-by":"publisher","first-page":"e1347","DOI":"10.1212\/WNL.0000000000011524","volume":"96","author":"WJ Jagust","year":"2021","unstructured":"Jagust WJ, Landau SM (2021) Temporal dynamics of \u03b2-Amyloid accumulation in aging and Alzheimer disease. Neurology 96:e1347\u2013e1357. https:\/\/doi.org\/10.1212\/WNL.0000000000011524","journal-title":"Neurology"},{"key":"3606_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126355","author":"M Tolar","year":"2021","unstructured":"Tolar M, Hey J, Power A, Abushakra S (2021) Neurotoxic soluble amyloid oligomers drive Alzheimer\u2019s pathogenesis and represent a clinically validated target for slowing disease progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22126355","journal-title":"Int J Mol Sci"},{"key":"3606_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ana.23748","volume":"73","author":"TJ Esparza","year":"2013","unstructured":"Esparza TJ, Zhao H, Cirrito JR et al (2013) Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls. Ann Neurol 73:104\u2013119. https:\/\/doi.org\/10.1002\/ana.23748","journal-title":"Ann Neurol"},{"key":"3606_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-physchem-050317-021322","volume":"69","author":"TCT Michaels","year":"2018","unstructured":"Michaels TCT, \u0160ari\u0107 A, Habchi J et al (2018) Chemical kinetics for bridging molecular mechanisms and macroscopic measurements of amyloid fibril formation. Annu Rev Phys Chem 69:273\u2013298.\u00a0https:\/\/doi.org\/10.1146\/annurev-physchem-050317-021322","journal-title":"Annu Rev Phys Chem"},{"key":"3606_CR5","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1073\/pnas.1922267117","volume":"117","author":"AJ Dear","year":"2020","unstructured":"Dear AJ, Michaels TCT, Meisl G et al (2020) Kinetic diversity of amyloid oligomers. Proc Natl Acad Sci 117:12087\u201312094. https:\/\/doi.org\/10.1073\/pnas.1922267117","journal-title":"Proc Natl Acad Sci"},{"key":"3606_CR6","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1021\/bi701899y","volume":"47","author":"AM Morris","year":"2008","unstructured":"Morris AM, Watzky MA, Agar JN, Finke RG (2008) Fitting neurological protein aggregation kinetic data via a 2-step, Minimal\/Ockham\u2019s Razor model: The Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth. Biochemistry 47:2413\u20132427. https:\/\/doi.org\/10.1021\/bi701899y","journal-title":"Biochemistry"},{"key":"3606_CR7","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1021\/acschemneuro.7b00251","volume":"8","author":"IA Iashchishyn","year":"2017","unstructured":"Iashchishyn IA, Sulskis D, Ngoc MN et al (2017) Finke-Watzky two-step nucleation-autocatalysis model of S100A9 amyloid formation: Protein misfolding as nucleation event. ACS Chem Neurosci 8:2152\u20132158. https:\/\/doi.org\/10.1021\/acschemneuro.7b00251","journal-title":"ACS Chem Neurosci"},{"key":"3606_CR8","doi-asserted-by":"publisher","first-page":"20240652","DOI":"10.1098\/rspa.2024.0652","volume":"481","author":"AV Kuznetsov","year":"2025","unstructured":"Kuznetsov AV (2025) A criterion characterizing accumulated neurotoxicity of A\u03b2 oligomers in Alzheimer\u2019s disease. Proc Royal Soc A 481:20240652. https:\/\/doi.org\/10.1098\/rspa.2024.0652","journal-title":"Proc Royal Soc A"},{"key":"3606_CR9","doi-asserted-by":"publisher","first-page":"041003","DOI":"10.1115\/1.4067701","volume":"147","author":"AV Kuznetsov","year":"2025","unstructured":"Kuznetsov AV (2025) Evaluating the combined neurotoxicity of amyloid beta and tau oligomers in Alzheimer\u2019s disease: A novel cellular-level criterion. ASME J Biomech Eng 147:041003. https:\/\/doi.org\/10.1115\/1.4067701","journal-title":"ASME J Biomech Eng"},{"key":"3606_CR10","doi-asserted-by":"publisher","unstructured":"Kuznetsov AV (2025) Predicting biological age using an accumulated neurotoxicity biomarker for amyloid beta oligomers. bioRxiv. https:\/\/doi.org\/10.1101\/2025.02.28.640920","DOI":"10.1101\/2025.02.28.640920"},{"key":"3606_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1567205012666141218140953","volume":"12","author":"RJ Baranello","year":"2015","unstructured":"Baranello RJ, Bharani KL, Padmaraju V et al (2015) Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer\u2019s disease. Curr Alzheimer Res 12:32\u201346. https:\/\/doi.org\/10.2174\/1567205012666141218140953","journal-title":"Curr Alzheimer Res"},{"key":"3606_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.neurobiolaging.2006.12.001","volume":"29","author":"A Majumdar","year":"2008","unstructured":"Majumdar A, Chung H, Dolios G et al (2008) Degradation of fibrillar forms of Alzheimer\u2019s amyloid beta-peptide by macrophages. Neurobiol Aging 29:707\u2013715. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.12.001","journal-title":"Neurobiol Aging"},{"key":"3606_CR13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s10433-022-00735-w","volume":"19","author":"RE Mark","year":"2022","unstructured":"Mark RE, Brehmer Y (2022) Preclinical Alzheimer\u2019s dementia: a useful concept or another dead end? Eur J Ageing 19:997\u20131004. https:\/\/doi.org\/10.1007\/s10433-022-00735-w","journal-title":"Eur J Ageing"},{"key":"3606_CR14","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1021\/acschemneuro.4c00127","volume":"15","author":"AJ Dear","year":"2024","unstructured":"Dear AJ, Thacker D, Wennmalm S et al (2024) A\u03b2 oligomer dissociation is catalyzed by fibril surfaces. ACS Chem Neurosci 15:2296\u20132307. https:\/\/doi.org\/10.1021\/acschemneuro.4c00127","journal-title":"ACS Chem Neurosci"},{"key":"3606_CR15","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1021\/bi0501030","volume":"44","author":"J Bieschke","year":"2005","unstructured":"Bieschke J, Zhang Q, Powers ET et al (2005) Oxidative metabolites accelerate Alzheimer\u2019s amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 44:4977\u20134983. https:\/\/doi.org\/10.1021\/bi0501030","journal-title":"Biochemistry"},{"key":"3606_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41443-3","volume":"9","author":"M Querol-Vilaseca","year":"2019","unstructured":"Querol-Vilaseca M, Colom-Cadena M, Pegueroles J et al (2019) Nanoscale structure of amyloid-\u03b2 plaques in Alzheimer\u2019s disease. Sci Rep 9:5181. https:\/\/doi.org\/10.1038\/s41598-019-41443-3","journal-title":"Sci Rep"},{"key":"3606_CR17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/cbic.201900097","volume":"20","author":"JA Raskatov","year":"2019","unstructured":"Raskatov JA (2019) What is the \u201crelevant\u201d amyloid \u03b242 concentration? Chembiochem 20:1725\u20131726. https:\/\/doi.org\/10.1002\/cbic.201900097","journal-title":"Chembiochem"},{"key":"3606_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115056","volume":"10","author":"C Grotz","year":"2015","unstructured":"Grotz C, Letenneur L, Bonsang E et al (2015) Retirement age and the age of onset of Alzheimer\u2019s disease: results from the ICTUS study. PLoS One 10:e0115056. https:\/\/doi.org\/10.1371\/journal.pone.0115056","journal-title":"PLoS One"},{"key":"3606_CR19","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Molecular psychiatry 26:5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Molecular psychiatry"},{"key":"3606_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.archger.2009.09.035","volume":"49","author":"O Zanetti","year":"2009","unstructured":"Zanetti O, Solerte SB, Cantoni F (2009) Life expectancy in Alzheimer\u2019s disease (AD). Archives of Gerontology and Geriatrics 49:237\u2013243. https:\/\/doi.org\/10.1016\/j.archger.2009.09.035","journal-title":"Archives of Gerontology and Geriatrics"},{"key":"3606_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015709","volume":"5","author":"J Waters","year":"2010","unstructured":"Waters J (2010) The concentration of soluble extracellular amyloid-\u03b2 protein in acute brain slices from CRND8 mice. PloS One 5:e15709. https:\/\/doi.org\/10.1371\/journal.pone.0015709","journal-title":"PloS One"},{"key":"3606_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.xphs.2018.01.013","volume":"107","author":"RE Cavicchi","year":"2018","unstructured":"Cavicchi RE, King J, Ripple DC (2018) Measurement of average aggregate density by sedimentation and Brownian motion analysis. J Pharm Sci 107:1304\u20131312. https:\/\/doi.org\/10.1016\/j.xphs.2018.01.013","journal-title":"Journal of pharmaceutical sciences"},{"key":"3606_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.103027","volume":"299","author":"E Dawkins","year":"2023","unstructured":"Dawkins E, Derks RJE, Schifferer M et al (2023) Membrane lipid remodeling modulates \u03b3-secretase processivity. Journal of Biological Chemistry 299:103027. https:\/\/doi.org\/10.1016\/j.jbc.2023.103027","journal-title":"Journal of Biological Chemistry"},{"key":"3606_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1385\/MN:27:2","volume":"27","author":"H Nakanishi","year":"2003","unstructured":"Nakanishi H (2003) Microglial functions and proteases. Mol Neurobiol 27:163\u2013176. https:\/\/doi.org\/10.1385\/MN:27:2","journal-title":"Mol Neurobiol"},{"key":"3606_CR25","doi-asserted-by":"publisher","DOI":"10.1115\/1.4064969","volume":"146","author":"AV Kuznetsov","year":"2024","unstructured":"Kuznetsov AV (2024) Numerical and analytical simulation of the growth of amyloid-\u03b2 plaques. Journal of Biomechanical Engineering 146:061004. https:\/\/doi.org\/10.1115\/1.4064969","journal-title":"Journal of Biomechanical Engineering"},{"key":"3606_CR26","doi-asserted-by":"publisher","first-page":"11959","DOI":"10.1021\/ja8017412","volume":"130","author":"MA Watzky","year":"2008","unstructured":"Watzky MA, Finney EE, Finke RG (2008) Transition-metal nanocluster size vs formation time and the catalytically effective nucleus number: a mechanism-based treatment. J Am Chem Soc 130:11959\u201311969. https:\/\/doi.org\/10.1021\/ja8017412","journal-title":"J Am Chem Soc"},{"key":"3606_CR27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46:860\u2013866. https:\/\/doi.org\/10.1002\/1531-8249(199912)46:6%3C860::AID-ANA8%3E3.0.CO;2-M","journal-title":"Ann Neurol"},{"key":"3606_CR28","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.3390\/ijms13067303","volume":"13","author":"LN Zhao","year":"2012","unstructured":"Zhao LN, Long HW, Mu Y, Chew LY (2012) The toxicity of amyloid \u00df oligomers. Int J Mol Sci 13:7303\u20137327. https:\/\/doi.org\/10.3390\/ijms13067303","journal-title":"Int J Mol Sci"},{"key":"3606_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta U, Nilson AN, Kayed R (2016) The role of amyloid-\u03b2 oligomers in toxicity, propagation, and immunotherapy. EBioMedicine 6:42\u201349. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.035","journal-title":"EBioMedicine"},{"key":"3606_CR30","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"G Chen","year":"2017","unstructured":"Chen G, Xu T, Yan Y et al (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacologica Sinica 38:1205\u20131235. https:\/\/doi.org\/10.1038\/aps.2017.28","journal-title":"Acta Pharmacologica Sinica"},{"key":"3606_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, Strooper BD (2012) The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nature Neuroscience 15:349\u2013357. https:\/\/doi.org\/10.1038\/nn.3028","journal-title":"Nature Neuroscience"},{"key":"3606_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129:183\u2013206. https:\/\/doi.org\/10.1007\/s00401-015-1386-3","journal-title":"Acta Neuropathol"},{"key":"3606_CR33","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1002\/alz.13761","volume":"20","author":"A Bollack","year":"2024","unstructured":"Bollack A, Collij LE, Garc\u00eda DV et al (2024) Investigating reliable amyloid accumulation in Centiloids: results from the AMYPAD Prognostic and Natural History Study. Alzheimer\u2019s & Dementia 20:3429\u20133441. https:\/\/doi.org\/10.1002\/alz.13761","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"3606_CR34","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41556-024-01423-w","volume":"26","author":"D Dormann","year":"2024","unstructured":"Dormann D, Lemke EA (2024) Adding intrinsically disordered proteins to biological ageing clocks. Nature Cell Biology 26:851\u2013858. https:\/\/doi.org\/10.1038\/s41556-024-01423-w","journal-title":"Nature Cell Biology"},{"key":"3606_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jalz.2012.11.005","volume":"9","author":"T Yang","year":"2013","unstructured":"Yang T, Hong S, O\u2019Malley T et al (2013) New ELISAs with high specificity for soluble oligomers of amyloid \u03b2-protein detect natural A\u03b2 oligomers in human brain but not CSF. Alzheimer\u2019s Dement 9:99\u2013112. https:\/\/doi.org\/10.1016\/j.jalz.2012.11.005","journal-title":"Alzheimer\u2019s Dement"},{"key":"3606_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ (2008) Soluble oligomers of the amyloid \u03b2-protein impair synaptic plasticity and behavior. Behavioural Brain Research 192:106\u2013113. https:\/\/doi.org\/10.1016\/j.bbr.2008.02.016","journal-title":"Behavioural Brain Research"},{"key":"3606_CR37","doi-asserted-by":"publisher","DOI":"10.1042\/AN20100025","volume":"3","author":"Y He","year":"2011","unstructured":"He Y, Cui J, Lee J-M et al (2011) Prolonged exposure of cortical neurons to oligomeric amyloid-\u03b2 impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (-)-epigallocatechin-3-gallate. ASN Neuro 3:e00050. https:\/\/doi.org\/10.1042\/AN20100025","journal-title":"ASN Neuro"},{"key":"3606_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.600084","volume":"13","author":"A Hector","year":"2021","unstructured":"Hector A, Brouillette J (2021) Hyperactivity induced by soluble amyloid-\u03b2 oligomers in the early stages of Alzheimer\u2019s disease. Frontiers in Molecular Neuroscience 13:2020. https:\/\/doi.org\/10.3389\/fnmol.2020.600084","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"3606_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.dadm.2018.06.007","volume":"10","author":"D Goyal","year":"2018","unstructured":"Goyal D, Tjandra D, Migrino RQ et al (2018) Characterizing heterogeneity in the progression of Alzheimer\u2019s disease using longitudinal clinical and neuroimaging biomarkers. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 10:629\u2013637. https:\/\/doi.org\/10.1016\/j.dadm.2018.06.007","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"3606_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimers-disease - the amyloid cascade hypothesis. Science 256:184\u2013185. https:\/\/doi.org\/10.1126\/science.1566067","journal-title":"Science"},{"key":"3606_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science"},{"key":"3606_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"3606_CR43","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CRJ Jack","year":"2013","unstructured":"Jack CRJ, Holtzman DM (2013) Biomarker modeling of Alzheimer\u2019s disease. Neuron 80:1347\u20131358. https:\/\/doi.org\/10.1016\/j.neuron.2013.12.003","journal-title":"Neuron"},{"key":"3606_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P et al (2013) Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12:357\u2013367. https:\/\/doi.org\/10.1016\/S1474-4422(13)70044-9","journal-title":"Lancet Neurol"},{"key":"3606_CR46","doi-asserted-by":"publisher","DOI":"10.1177\/15593258251367588","volume":"23","author":"S Sutou","year":"2025","unstructured":"Sutou S (2025) Questioning the Linear No-Threshold Model (LNT): lessons from Hiroshima\/Nagasaki and Fukushima. Dose Response 23:15593258251367588. https:\/\/doi.org\/10.1177\/15593258251367588","journal-title":"Dose Response"},{"key":"3606_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00411-024-01092-1","volume":"63","author":"A Wojcik","year":"2024","unstructured":"Wojcik A, Z\u00f6lzer F (2024) The scientific nature of the linear no-threshold (LNT) model used in the system of radiological protection. Radiat Environ Biophys 63:483\u2013489. https:\/\/doi.org\/10.1007\/s00411-024-01092-1","journal-title":"Radiat Environ Biophys"},{"key":"3606_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2026.103058","volume":"117","author":"W Fu","year":"2026","unstructured":"Fu W, Ho P-L (2026) Blood-based biomarkers for Alzheimer\u2019s disease: advances in early detection and monitoring of age-related neurodegeneration. Ageing Res Rev 117:103058. https:\/\/doi.org\/10.1016\/j.arr.2026.103058","journal-title":"Ageing Res Rev"}],"container-title":["Medical &amp; Biological Engineering &amp; Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-026-03606-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11517-026-03606-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-026-03606-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:22:53Z","timestamp":1786522973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11517-026-03606-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3606"],"URL":"https:\/\/doi.org\/10.1007\/s11517-026-03606-z","relation":{},"ISSN":["0140-0118","1741-0444"],"issn-type":[{"value":"0140-0118","type":"print"},{"value":"1741-0444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}